10.3 Interventional & Surgical Management of BPO

10.3 Interventional & Surgical Management of BPO

Interventional and surgical therapies represent the definitive treatment modality for benign prostatic obstruction (BPO). While medical therapy effectively controls symptoms in early or moderately advanced disease, surgical de-obstruction is considered when conservative/medical treatment is ineffective, poorly tolerated or unsuitable, and is usually needed for important obstruction-related complications. Modern endourology offers an expansive armamentarium ranging from classic electrosurgical resection to advanced laser enucleation, tissue vaporization, and novel minimally invasive office-based implants.

---

1. Indications for Surgical Intervention

In accordance with EAU guidelines, indications for intervention are categorized into absolute operation indications and relative, quality-of-life-driven indications.

Absolute Surgical Indications

These presentations usually require surgery after stabilization and assessment of operative fitness; temporary or longer-term drainage may be needed when surgery is unsuitable:

1. Recurrent or Refractory Retention / Overflow Incontinence: Persistent or recurrent emptying failure supports surgery. Alpha-blockers can assist TWOC after AUR, but one failed TWOC is not a universal definition mandating immediate surgery.
2. Recurrent Urinary Tract Infections (UTIs): Documented recurrent bacterial infections directly attributable to elevated post-void residual urine and urinary stasis.
3. Recurrent Macroscopic Hematuria: Gross prostatic hematuria refractory to medical management (including a trial of 5-ARIs, which suppress microvascular endothelial proliferation by downregulating VEGF).
4. Bladder Calculi (Vesical Lithiasis): Stones developing secondary to chronic urinary stasis, infection, and outflow impedance.
5. BPO-Related Upper-Tract Dilatation: Hydronephrosis attributable to obstruction is an indication with or without renal insufficiency; drain and stabilize clinically important obstructive retention before definitive treatment.
6. Large Decompensating Bladder Diverticula: Saccular mucosal herniations that impair detrusor emptying efficiency, promote refractory infections, or harbor occult intra-diverticular malignancy.

Relative Indications

• Bothersome moderate-to-severe LUTS refractory to optimal medical therapy.
• Patient unwillingness or financial/logistical inability to maintain lifelong medical therapy.
• Intolerable adverse effects from pharmacotherapy (e.g., severe postural hypotension, anejaculation, or erectile dysfunction).

---

2. Surgical Modality Selection by Prostate Volume

Measure prostate volume by ultrasound (transabdominal or transrectal) or use available cross-sectional imaging. Volume helps select treatment alongside median-lobe anatomy, comorbidities, anaesthesia, preferences, equipment and operator expertise. The diagram gives usual size ranges, not exclusive compartments:

                               PROSTATE VOLUME STRATIFICATION
                                             |
       +-------------------------------------+-------------------------------------+
       |                                     |                                     |
  < 30 mL                                30 - 80 mL                             > 80 mL
       |                                     |                                     |
+--------------+                    +------------------+                   +------------------+
|     TUIP     |                    |      M-TURP      |                   |   EEP (HoLEP,    |
| (Incision of |                    |      B-TURP      |                   |  ThuLEP, B-TUEP) |
|   Prostate)  |                    |   GreenLight PVP |                   |        OR        |
+--------------+                    | MIST (PUL/Rezum) |                   |   Open Simple    |
                                    +------------------+                   |   Prostatectomy  |
                                                                           +------------------+
  HoLEP/other enucleation also suit smaller glands; PUL has its own <70-mL/no-middle-lobe criteria.
  Water-vapour treatment is discussed separately; options do not have equal evidence.

---

3. Small Prostates (< 30 mL): Transurethral Incision of the Prostate (TUIP)

In men with small prostate glands (< 30 mL) without an obstructing median lobe, Transurethral Incision of the Prostate (TUIP)—originally described by Orandi—is the surgical procedure of choice.

Technique & Advantages

• Technique: Using a Collings knife or monopolar/bipolar resectoscope loop, full-thickness longitudinal incisions are made through the bladder neck, prostate adenoma, and surgical capsule from immediately distal to the ureteral orifices down to the verumontanum. Incisions may be bilateral (at the 5 and 7 o'clock positions) or unilateral (at the 6 o'clock position).
• Clinical Outcomes: TUIP offers symptom improvement similar to TURP in small glands, but generally less Qmax improvement and a higher retreatment rate. Counsel about this trade-off.
• Key Advantages: Shorter operative time (<30 minutes), minimal intraoperative hemorrhage, virtually zero risk of TUR syndrome, and a significantly lower incidence of retrograde ejaculation (~20% to 25% for TUIP versus >70% for standard TURP).

---

4. Intermediate Prostates (30 to 80 mL): Transurethral Resection of the Prostate (TURP)

TURP has stood for decades as the reference surgical standard against which all other des-obstructive interventions are compared.

Monopolar vs. Bipolar TURP

TUR Syndrome: Pathophysiology & Crisis Management

Transurethral Resection (TUR) Syndrome is an acute, life-threatening complication classically associated with monopolar TURP, resulting from the rapid intravascular absorption of large volumes of non-conductive, hypoosmolar irrigation fluid (1.5% glycine) through opened prostatic venous sinuses.

• Absorption Dynamics: During prolonged resections or when intravesical irrigation pressure exceeds prostatic venous pressure (>10–15 mmHg), fluid absorption rates can reach 20 to 30 mL/min, with total systemic absorption exceeding 1,000 to 2,000 mL.
• Pathophysiological Triad:
  1. Acute Dilutional Hypoosmolar Hyponatremia: Severe drop in serum sodium concentration (<125 mmol/L, and in severe crises <115 mmol/L) accompanied by acute serum hypoosmolarity (<260 mOsm/kg). This triggers rapid osmotic water movement across the blood-brain barrier, resulting in cerebral edema, intracranial hypertension, headache, restlessness, confusion, visual disturbances, seizures, and fatal brainstem herniation.
  2. Hypervolemic Circulatory Fluid Overload: Rapid expansion of intravascular volume produces hypertension and reflex bradycardia, potentially progressing to acute left ventricular strain, pulmonary edema, cyanosis, and circulatory collapse.
  3. Solute Neurotoxicity & Toxicity: Glycine is an inhibitory neurotransmitter in the central nervous system and retina. Excessive glycine can disturb retinal neurotransmission, causing visual blurring or transient blindness. Hepatic oxidative deamination of glycine generates massive quantities of ammonia (causing secondary hyperammonemic encephalopathy) and glyoxylate (oxalate).

                     MASSIVE INTRAVASCULAR ABSORPTION OF 1.5% GLYCINE
                                            |
       +------------------------------------+------------------------------------+
       |                                    |                                    |
  DILUTIONAL HYPONATREMIA              HYPERVOLEMIA                       GLYCINE TOXICITY
  (Serum Na < 120 mmol/L)        (Circulatory Overload)              (Neurotransmitter Effect)
       |                                    |                                    |
  Cerebral Edema                       Hypertension                         Visual Disturbance
  Headache, Confusion                  Reflex Bradycardia                   Transient Blindness
  Seizures, Coma                       Pulmonary Edema                      Ammonia Toxicity

Immediate Crisis Management Protocol

1. Abort the Procedure: Immediately terminate resection, achieve rapid hemostasis, and place a 3-way Foley catheter with gentle balloon traction.
2. Respiratory & Circulatory Stabilization: Administer high-flow supplemental oxygen, intubate if comatose, and optimize ventilation.
3. Assess and Monitor: Stop further irrigant absorption and unnecessary IV fluid; check sodium, osmolality, acid–base status and urine output, with continuous cardiorespiratory monitoring and urgent anaesthetic/critical-care support. Use a loop diuretic for clinically important pulmonary oedema/volume overload, not routinely to force diuresis in every patient.
4. Treat Symptomatic Hyponatraemia: Neurological symptoms require prompt, monitored 3% hypertonic saline. A European emergency approach uses 150 mL over 20 minutes, followed by reassessment of sodium and symptoms; severe symptoms may require repeat boluses towards an initial rise of about 5 mmol/L. Do not delay rescue treatment to meet a slow daily correction target.

Bipolar Safety Advantage

Because B-TURP utilizes isotonic 0.9% normal saline, intravascular fluid absorption does not produce hypoosmolar hyponatremia. Fluid overload can still occur with substantial saline absorption and requires monitoring. Saline avoids the hypoosmolar irrigant load and glycine toxicity; it does not make prolonged surgery or excessive absorption harmless.

---

5. Large Prostates (> 80 mL): Open Simple Prostatectomy vs. Endoscopic Enucleation

For severely enlarged prostates (> 80 mL), standard TURP becomes less attractive because operative time and complication risk increase. Enucleation is usually a better option, but 80 mL is a selection threshold rather than an absolute TURP contraindication.

Open Simple Prostatectomy (OSP)

Historically, open adenomectomy was the sole option for large glands:

• Freyer Procedure (Transvesical): The bladder is opened through a vertical midline cystotomy, and the surgeon enucleates the adenoma blunt-digitally along the surgical capsule from inside the bladder lumen.
• Millin Procedure (Retropubic): The anterior prostatic capsule is incised transversely below the bladder neck without entering the peritoneal cavity or opening the bladder dome, providing superior visualization of the prostatic apex and apical hemostasis.
• Clinical Status: Highly effective at achieving complete des-obstruction, but associated with high perioperative morbidity: transfusion rates of 5% to 15%, prolonged catheterization (5 to 8 days), long hospital stays, and wound complications.

Endoscopic Enucleation of the Prostate (EEP)

EEP has revolutionized modern endourology, matching the anatomical radicality of open enucleation through a purely transurethral approach:

• Modality Types: Holmium Laser Enucleation of the Prostate (HoLEP), Thulium Laser Enucleation (ThuLEP), and Bipolar Transurethral Enucleation of the Prostate (B-TUEP).
• Surgical Technique: Using laser energy or a bipolar mechanical spatula tip, the surgeon establishes the anatomical plane between the adenoma and the surgical capsule at the level of the verumontanum. The entire adenoma (lateral and median lobes) is dissected retrogradely off the capsule along the relatively avascular surgical plane towards the bladder neck and pushed entirely into the vesical lumen (en bloc or three-lobe technique). The adenoma is then removed, commonly by mechanical morcellation under direct vision; bipolar enucleation may instead be followed by resection of the enucleated tissue.
• EAU Guideline Recommendation: HoLEP is strongly recommended as an alternative to TURP or open prostatectomy, with durable symptom/flow improvement and a favourable perioperative profile. It can treat glands across a wide size range, including >80 mL. EAU recommendations for thulium and bipolar enucleation are weaker and depend on expertise. Offer open surgery for >80 mL when endoscopic enucleation is unavailable; catheter duration and bleeding are not guaranteed.

---

6. Laser Vaporization: GreenLight PVP

Photoselective Vaporization of the Prostate (GreenLight PVP) utilizes a 532 nm wavelength laser (potassium-titanyl-phosphate [KTP] or lithium-triborate [LBO]) that is selectively and intensely absorbed by oxyhemoglobin.

• Mechanism: Absorption of 532 nm energy in capillary blood creates instantaneous optical tissue vaporization with a superficial 1 to 2 mm coagulation margin, producing near-bloodless ablation.
• Clinical Indications: PVP is an alternative to TURP for 30–80-mL glands. EAU weakly offers it to selected men receiving anticoagulant/antiplatelet therapy with glands <80 mL. Plan antithrombotic management individually; laser haemostasis does not guarantee safety during uninterrupted therapeutic anticoagulation.
• Limitations: Does not yield tissue for histopathological analysis; prolonged dysuria occurs in 10% to 15% of patients.

---

7. Minimally Invasive Surgical Therapies (MIST)

Minimally invasive options target sexually active men with mild-to-moderate anatomical enlargement who seek rapid recovery while avoiding the ejaculatory and erectile complications associated with TURP and enucleation.

Prostatic Urethral Lift (PUL / UroLift)

• Technique: Permanent transprostatic suture implants—comprising a nitinol capsular tab and a stainless steel urethral end-piece joined by non-absorbable monofilament suture—are deployed transurethrally under cystoscopic guidance. Implants retract the obstructing lateral lobes laterally toward the prostatic capsule, expanding the anterior urethral lumen.
• Major Advantage: Usually preserves erectile and ejaculatory function. L.I.F.T. reported no new sustained dysfunction over five years, but this is not a guarantee for every patient. Retreatment is more frequent than after TURP.
• Anatomical Restrictions: The EAU recommendation is for prostates <70 mL with no middle lobe, in men prioritizing ejaculation. Distinguish this recommendation from trial entry ranges or device-specific expanded indications.

Convective Water Vapor Thermal Therapy (Rezum)

• Technique: Radiofrequency energy vaporizes sterile water into convective steam (100°C), which is injected into the adenoma in 9-second pulses via a transurethral needle. As steam condenses, it releases 540 cal/g of latent heat energy, disrupting cell membranes and inducing instantaneous coagulative necrosis. The necrotic tissue is resorbed by macrophages over 2 to 3 months.
• Clinical Profile: An office-based option, often under local anaesthesia with or without sedation. Pivotal evidence concerns 30–80-mL glands, including treatment of median lobes, with generally preserved sexual function. EAU discusses it among techniques under investigation: comparative evidence versus reference surgery and long-term retreatment counselling remain important.

Robotic Waterjet Ablation (Aquablation)

• Combines transrectal ultrasound image planning with a high-velocity, heat-free saline jet to ablate prostatic tissue robotically.
• Image planning can spare structures important for ejaculation. Antegrade ejaculation was preserved in about 81–90% in WATER/WATER II; haemostasis may require cautery. EAU strongly offers Aquablation as an alternative to TURP for 30–80-mL glands; evidence in 80–150-mL glands is also available.

---

Surgical Modality Selection Algorithm by Prostate Size & Bleeding Risk